激发感冒瘤:多种OMIC驱动的策略来克服免疫逃避并恢复免疫监测
Xinyao Huang1, Renjun Gu2,3, Ziyun Li4
1The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Oncology research
|October 6, 2025
概括
本综述详细介绍了多omics数据如何揭示了感冒瘤中的免疫逃避机制,并提出了向治疗方法. 策略旨在将这些瘤转化为"热"环境,以进行有效的免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
- 代谢学 代谢学 代谢学
背景情况:
- 感冒瘤的特点是免疫细胞透率低和免疫抑制性瘤微环境 (TME),导致对免疫治疗的反应不佳.
- 了解免疫逃避机制对于开发有效的癌症治疗至关重要.
研究的目的:
- 系统地审查冷瘤中的免疫逃避机制,使用多omics数据.
- 总结治疗策略,以克服免疫逃避并提高免疫治疗的疗效.
主要方法:
- 整合基因组,转录组,蛋白质组,代谢组和空间多组数据.
- 关于感冒瘤和免疫治疗的研究的系统文献综述.
主要成果:
- 已发现的关键免疫逃避机制包括WNT/β-catenin激活,TGF-β免疫抑制,代谢重编程 (乳酸积累) 和免疫检查点分子表达.
- 有前途的治疗策略包括向免疫抑制途径 (PD-1/PD-L1,TGF-β),重塑TME (化学因子,瘤病毒,血管正常化),代谢干预 (LDHA,GLS抑制),新抗原疫苗和工程细胞疗法 (TCR-T,NK细胞).
- 表观遗传调节 (HDAC 抑制剂) 和m6A RNA 修饰显示出逆转免疫逃避的潜力.
结论:
- 多omics集成提供了针对感冒瘤的精密免疫治疗的关键见解.
- 临床翻译的挑战包括数据异质性,毒性和临床前模型的局限性.
- 未来的研究应该专注于动态的多组学和智能治疗设计,以将寒冷的瘤转化为"热"的瘤,以实现免疫治疗的突破.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Immune Surveillance by NK Cells and Phagocytes
7.8K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


